Stock A326030 SK BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SK Biopharmaceuticals Co., Ltd.

Equities

A326030

KR7326030004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
85,900 KRW +2.87% Intraday chart for SK Biopharmaceuticals Co., Ltd. +2.02% -14.44%
Jan. 30 SK Biopharmaceuticals Swings to Profit in Q4 MT
2023 SK Group Advances Net Zero Transition via Key Renewable Energy Deal MT

Evolution of the average Target Price on SK Biopharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

30014af20ce2db0.ruqmvyWbuzDXIhfREcjMkWWbW-vkdDwaQ9M3cZKl1jE.zNr1h3H03GmZF1qoQ6qpoh_YHbOXJ1JtAZx6JMPOpnP3v8j3csrLXpFRTg~ddaf6bcb3c7028797506caa2eab541a9

Analyst Recommendations on SK Biopharmaceuticals Co., Ltd.

South Korean Shares Close Higher on Optimism Over China's One-Year Loan Prime Rate Cut; SK Biopharma Adds 2% MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
85,900 KRW
Average target price
106,133 KRW
Spread / Average Target
+23.55%
High Price Target
130,000 KRW
Spread / Highest target
+51.34%
Low Price Target
51,000 KRW
Spread / Lowest Target
-40.63%

Consensus detail

Consensus revision (last 18 months)

Ratings for SK Biopharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A326030 Stock
  4. Consensus SK Biopharmaceuticals Co., Ltd.